Phase I/II Safety and Immunogenicity of Pandemic Live Attenuated Influenza Vaccine (PLAIV) Candidate Strain A/17/CA/2009/38 (H1N1) in Healthy Thais

NCT01666262 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

363

Enrollment

OTHER

Sponsor class

Conditions

Healthy

Interventions

BIOLOGICAL: Vaccine A/17/CA/2009/38 (H1N1)
OTHER: Placebo:Stabilizer

Sponsor

Mahidol University